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Abstract
In the present study, we used tumor necrosis factor-R1 knock out mice (TNF-αR1KO) to
understand the roles of TNF-α on epithelial function in models of carrageenan-induced acute lung
inflammation. In order to elucidate whether the observed anti-inflammatory status is related to the
inhibition of TNF-α, we also investigated the effect of etanercept, a TNF-α soluble receptor
construct, on lung TJ function. Pharmacological and genetic TNF-α inhibition significantly reduced
the degree of (1) TNF-α production in pleural exudates and in the lung tissues, (2) the inflammatory
cell infiltration in the pleural cavity as well as in the lung tissues (evaluated by MPO activity), (3) the
alteration of ZO-1, Claudin-2, Claudin-4, Claudin-5 and β-catenin (immunohistochemistry) and (4)
apoptosis (TUNEL staining, Bax, Bcl-2 expression). Taken together, our results demonstrate that
inhibition of TNF-α reduces the tight junction permeability in the lung tissues associated with acute
lung inflammation, suggesting a possible role of TNF-α on lung barrier dysfunction.
Introduction
An important consequence of acute lung injury is the dis-
ruption of the paracellular alveolar permeability barrier
[1]. The permeability barrier in terminal airspaces of the
lung is due in large part to tight junctions between alveo-
lar epithelial cells, which regulate the flow of molecules
between apical and basolateral compartments [2,3].
Transmembrane proteins in the occludin and claudin
families are the major transmembrane structural elements
of tight junctions [4,5]. It has previously been shown that
alveolar epithelial cells express occludin and zona occlu-
dens 1 (ZO-1) as part of the tight junction complex [6,7].
In addition to these components, the importance of clau-
dins in pulmonary barrier function is underscored by the
viability of occludin-deficient mice [8].
Moreover, is well known that airway epithelial cells per-
form many important functions, serving as an interface
between environmental stimuli and the lung paren-
chyma. Normally the lower airways are pristine, free of
bacterial flora or inflammatory cells, and are well pro-
tected by several layers of defenses including antimicro-
bial peptides, mucin, and ciliary action. There is a brisk
epithelial response to airway injury caused by many dif-
ferent mechanisms [9,10]. Acute lung inflammatory
response is also is associated to epithelial cytokine expres-
sion [11] as well as to the expression of the signaling cas-
cade leading to apoptosis (programmed cell death).
Activation of epithelial proinflammatory signaling cas-
cades is mediated by tumor Necrosis Factor (TNF)-α a
prototypic member of a cytokine family which regulates
essential biologic functions (e.g. cell differentiation, pro-
liferation, survival, apoptosis) and a broad spectrum of
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responses to stress and injury [12]. It is primarily pro-
duced by immune cells such as monocytes and macro-
phages, but it can also be released by many other cell
types, including acinar cells. Membrane bound or soluble
TNF-α interacts with two different surface receptors, TNF-
α receptor 1 (TNFR1), or p55, and TNF-α receptor 2
(TNFR2), or p75 [13]. Although the extracellular domains
of TNFR1 and TNFR2 are homologous and manifest sim-
ilar affinity for TNF-α, the cytoplasmic regions of the two
receptors are distinct and mediate different downstream
events. Although most cell lines and primary tissues
express both isoforms [14], most of the biological activi-
ties of TNF-α are mediated through TNF-R1 [15]. TNF-R2
is a poor inducer of apoptosis [16] and binding affinities
of soluble TNF-a are significantly higher to TNF-R1 [15].
After exposure to TNF-α, target cells may down-regulate
their responsiveness to the cytokine by shedding the
receptors into the circulation. A natural mechanism which
has been hypothesized to counteract excessive concentra-
tions of circulating TNF-α (and the subsequent enhanced
surface receptor activation) is the release of soluble recep-
tors. The two soluble receptor forms (sTNFR1 and
sTNFR2) have longer half lives than TNF-α, and their con-
centration may reflect TNF-α activity [17].
A primary role for TNF-α in inflammatory process (e.g.
sepsis, endotoxiemic shock and acute pancreatitis) is sug-
gested by several studies conducted upon cell lines, ani-
mal models and human beings [18-20]. In inflammation,
over-production of TNF-α is pivotal in the induction of
inflammatory genes, cell death, endothelial up-regulation
and in the recruitment and activation of immune cells
[21,22]. It has been also regarded as one of the major
mediators of systemic progression and tissue damage in
severe disease. However, the biologic significance of TNFR
shedding is unclear. It could represent a neutralizing
mechanism to counteract excessive TNF-α activity, but –
on the other hand – it has been suggested that in relatively
low concentrations sTNFR may serve as carriers to distant
organs. Furthermore, sTNFR stabilize TNF-α trimeric
structure thereby prolonging its half-life and augmenting
its biological effects [17]. Etanercept is a fully humanized
dimeric soluble form of the p75 TNF receptor that can
bind to two TNF-α molecules blocking their interaction
with cell surface TNFRs and rendering TNF-α biologically
inactive. TNF-α inactivation is one thousand times
stronger than inactivation by p75 monomeric TNFR
[23,24]. It inhibits the activity of TNF-α in vitro and has
been examined in vivo for its effects in different animal
model systems of inflammatory and autoimmune dis-
eases [25].
In addition, it has been demonstrated that TNF plays a
role in the control of epithelial permeability [26-29] as
well as in the regulation of pulmonary microvessels
endothelium [26]. Moreover, TNF at higher concentra-
tions leads to down-regulation of ZO-1 protein expression
and disturbance in junction localization of ZO-1 protein
and functional opening of tight junction barrier [29-31].
Base on this evidence, we have hypothesized that
increased production of TNF-α might lead to structural
and functional alterations in pulmonary TJ function in
vivo as a result of acute lung inflammation induced by
carrageenan in mice. Herein, we demonstrate that acute
lung injury is associated with decreased expression and
function of several TJ proteins in the lung epithelium.
Moreover, we also demonstrate that Etanercept treatment




Mice (4–5 weeks old, 20–22 g) with a targeted disruption
of the TNF-αR1 (TNF-α R1KO) and wild-type controls
(TNF-αWT) were purchased from Jackson Laboratories
(Charles River, Italy). The study was approved by the Uni-
versity of Messina Review Board for the care of animals.
The animals were housed in a controlled environment
and provided with standard rodent chow and water ad
libitum. Animal care was in compliance with regulations
in Italy (D.M. 116192), Europe (O.J. of E.C. L 358/1 12/
18/1986) and USA (Animal Welfare Assurance No A5594-
01, Department of Health and Human Services, USA).
Experimental groups for Carrageenin-induced pleurisy
Mice were randomly allocated into the following groups:
(i)  WT CAR group. WT mice were subjected to carra-
geenan-induced pleurisy (N = 10); (ii) CAR TNF-αR1KO
group. TNF-αR1KO mice were subjected to subjected to
carrageenan-induced pleurisy (N  = 10); (iii) WT Sham
group. WT mice were subjected to the surgical procedures
as the above groups except instead of carrageenan 100 µl
of saline solution were administered to the mice (N = 10);
(iv) TNF-αR1KO Sham group. TNF-αR1KO mice were sub-
jected to the surgical procedures as the above groups
except that instead of carrageenan 100 µl of saline solu-
tion were administered to the mice (N = 10); (v) CAR
WT+Etanercept group. Same as CAR WT group except for
the administration of Etanercept (5 mg/kg subcutane-
ously dissolved in saline solution) which was given at 2 h
before the carrageenan injection (N = 10); (vi) WT Sham
+Etanercept group. Same as the WT Sham group except for
the administration of Etanercept (5 mg/kg subcutane-
ously dissolved in saline solution) which was given at 2 h
before saline injection (N = 10);
Carrageenan-induced pleurisy
Carrageenan-induced pleurisy was induced as previously
described [32]. Mice were anesthetized with isofluraneRespiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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and submitted to a skin incision at the level of the left
sixth intercostals space. The underlying muscle was dis-
sected and saline (0.2 ml) or saline containing 1% (w/v)
λ-carrageenan (0.2 ml) was injected into the pleural cav-
ity. The skin incision was closed with a suture and the ani-
mals were allowed to recover. At 4 h and 24 h after the
injection of carrageenan, the animals were killed by inha-
lation of CO2. The chest was carefully opened and the
pleural cavity rinsed with 2 ml of saline solution contain-
ing heparin (5 U/ml) and indomethacin (10 µg/ml). The
exudate and washing solution were removed by aspiration
and the total volume measured. Any exudate, which was
contaminated with blood, was discarded. The amount of
exudate was calculated by subtracting the volume injected
(2 ml) from the total volume recovered. The leukocytes in
the exudate were suspended in phosphate-buffer saline
(PBS, 0.01 M, pH7.4) and counted with an optical micro-
scope in a Burker's chamber after vital Trypan Blue stain-
ing.
Histological examination
Lung biopsies were taken 4 h and 24 h after carrageenan
injection. Tissues biopsies were fixed for 1 week in 10 %
(w/v) PBS-buffered formaldehyde solution at room tem-
perature, dehydrated using graded ethanol and embedded
in Paraplast (Sherwood Medical, Mahwah, NJ, USA).
Lung sections were then deparaffinized with xylene,
stained with hematoxylin and eosin. All sections were
studied using light microscopy (Dialux 22 Leitz).
Measurement of cytokines
TNF-α production was evaluated in the pleural exudate
and lung tissues at 4 h and 24 h after the induction of
pleurisy by carrageenan injection as previously described
[33]. The assay was carried out using a colorimetric com-
mercial ELISA kit (Calbiochem-Novabiochem Corpora-
tion, Milan, Italy) with a lower detection limit of 10 pg/
ml.
Immunohistochemical localization of TNF-α, BAX- BCL-2 
Claudin-2, Claudin-4, Claudin-5, ZO-I and β-catenin
At 4 and 24 h after carrageenan injection, tissues were
fixed in 10% (w/v) PBS-buffered formaldehyde and 5 µm
sections were prepared from paraffin embedded tissues.
After deparaffinization, endogenous peroxidase was
quenched with 0.3% (v/v) hydrogen peroxide in 60% (v/
v) methanol for 30 min. Non-specific adsorption was
minimized by incubating the section in 2% (v/v) normal
goat serum in PBS for 20 min. Endogenous biotin or avi-
din binding sites were blocked by sequential incubation
for 15 min with biotin and avidin (DBA, Milan, Italy),
respectively. Sections were incubated overnight with 1)
with anti-TNF-α antibody (Santa Cruz, 1:100 in PBS w/v,)
or 3) with anti-Bax antibody (Santa Cruz, 1:50 in PBS v/v)
or 4) with anti-Bcl-2 antibody (Santa Cruz 1:100 in PBS v/
v). After deparaffinization, for Claudin-2, Claudin-4, Clau-
din-5, ZO-I and β-catenin  detection, slices were treated
with protease (type XIV, Sigma) (2 mg/ml) and for 10 min
at 37°C. Detection of BCL-2 and Bax was carried out after
boiling in citrate buffer, 0.01 M for 4 min. Sections were
incubated overnight with polyclonal rabbit anti-claudin-2
Claudin-4, Claudin-5, ZO-I and β-catenin antibody (1:100
in PBS, w/v). Sections were washed with PBS and incu-
bated with secondary antibody. Specific labeling was
detected with a biotin-conjugated goat anti-rabbit IgG and
avidin-biotin peroxidase complex (DBA, Milan, Italy).
The counter stain was developed with DAB (brown color)
and nuclear fast red (red background). To verify the bind-
ing specificity, some sections were also incubated with
only the primary antibody (no secondary) or with only
the secondary antibody (no primary). In these situations
no positive staining was found in the sections indicating
that the immunoreaction was positive in all the experi-
ments carried out. Immunocytochemistry photographs
(N  = 5) were assessed by densitometry as previously
described [34] by using Imaging Densitometer (AxioVi-
sion, Zeiss, Milan, Italy) and a computer program. In par-
ticular the densitometry analysis was carried out in section
in which the lung was orientated in order to observe all
the histological portions. In this type of section, is possi-
ble to evaluate the presence/absence or the alteration of
the distribution pattern.
Myeloperoxidase activity
Myeloperoxidase (MPO) activity, an indicator of poly-
morphonuclear leukocyte (PMN) accumulation, was
determined as previously described [35]. At the specified
time following injection of carrageenan, paw and lung tis-
sues were obtained and weighed, each piece homogenized
in a solution containing 0.5% (w/v) hexadecyltrimethyl-
ammonium bromide dissolved in 10 mM potassium
phosphate buffer (pH 7) and centrifuged for 30 min at
20,000 × g at 4°C. An aliquot of the supernatant was then
allowed to react with a solution of tetramethylbenzidine
(1.6 mM) and 0.1 mM hydrogen peroxide. The rate of
change in absorbance was measured spectrophotometri-
cally at 650 nm. MPO activity was defined as the quantity
of enzyme degrading 1 µmol of peroxide/min at 37°C
and was expressed in units per g of wet tissue.
TUNEL Assay
TUNEL assay was conducted by using a TUNEL detection
kit according to the manufacturer's instructions (Apotag,
HRP kit DBA, Milan, Italy). Briefly, sections were incu-
bated with 15 µg/ml proteinase K for 15 min at room tem-
perature and then washed with PBS. Endogenous
peroxidase was inactivated by 3% H2O2 for 5 min at room
temperature and then washed with PBS. Sections were
immersed in terminal deoxynucleotidyltransferase (TdT)
buffer containing deoxynucleotidyl transferase and bioti-Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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nylated dUTP in TdT buffer, incubated in a humid atmos-
phere at 37°C for 90 min, and then washed with PBS. The
sections were incubated at room temperature for 30 min
with anti-horseradish peroxidase-conjugated antibody,
and the signals were visualized with diaminobenzidine.
From each biopsy, at least 4 bronchiolar profiles were
evaluated under a light microscope at a ×20 magnification
for TUNEL-positive cells. The percentage is calculated as
the number of positive cells/total number of bronchial
epithelial cells.
Statistical evaluation
All values in the figures and text are expressed as mean ±
standard error of the mean (s.e.m.) from 10 mice for each
group. For the in vivo studies n represents the number of
animals studied. In the experiments involving histology
or immunohistochemistry, the figures shown are repre-
sentative at least three experiments (histological or immu-
nohistochemistry coloration) performed on different
experimental days on the tissues section collected from all
the animals in each group. The results were analyzed by
one-way ANOVA followed by a Bonferroni's post-hoc test
for multiple comparisons. A p-value of less than 0.05 was
considered significant.
Results
Effects of TNF-α gene deletion and Etanercept 
administration on TNFα production
To test whether TNF-α gene may modulate the inflamma-
tory process leading to structural and functional altera-
tions in pulmonary TJ function in vivo, we analyzed the
levels of this pro-inflammatory cytokine in TNF-αR1KO
and WT mice. A substantial increase of TNF-α production
was found in pleural exudates and in the lung tissues col-
lected from WT mice at 4 h and 24 h after carrageenan
injection (Fig 1). Pleural exudates and lung tissues pro-
duction of TNF-α were significantly reduced in carra-
geenan-injected TNF-αR1KO mice as well as in WT mice
treated with Etanercept (5 mg/kg administered s.c. 2 h
prior carrageenan) (Fig. 1). Therefore, we also evaluate the
TNF-α expression in the lung tissues by immunohisto-
chemical detection. No positive staining for TNF-α was
observed in the lung tissues collected at 4 h (data not
shown) and at 24 hours from sham WT mice (Fig. 2a) and
from sham TNF-αR1KO mice (Fig. 2b). On the contrary,
tissue sections obtained from WT animals at 4 h (Fig.
2csee densitometry analysis Fig. 3a) and at 24 hours (Fig.
2dsee densitometry analysis Fig. 3b) after carrageenan
injection demonstrate positive staining for TNF-α mainly
localized in the infiltrated inflammatory cells, pneumo-
cytes as well as in vascular wall. In carrageenan-injected
TNF-αR1KO mice, no positive staining for TNF-α were
observed in the lung tissues collected at 4 h (Fig. 2esee
densitometry analysis Fig. 3a) and at 24 hours (Fig. 2fsee
densitometry analysis Fig. 3b). Similarly, the treatment
of WT mice with Etanercept (5 mg/kg administered s.c. 2
h prior carrageenan) visibly and significantly reduced the
positive staining for TNF-α in the infiltrated inflammatory
cells, pneumocytes as well as in vascular wall in the lung
tissues collected at 4 h (Fig. 2gsee densitometry analysis
Fig. 3a) and at 24 hours (Fig. 2hsee densitometry analy-
sis Fig. 3a).
Effects of TNF-α gene deletion and Etanercept administra- tion on TNFα levels Figure 1
Effects of TNF-α gene deletion and Etanercept administra-
tion on TNFα levels. TNF-α production was evaluated in the 
pleural exudates (a) and lung tissues (b) collected at 4 h and 
24 h after carrageenan administration using a colorimetric 
commercial ELISA kit. A significant production TNF-α was 
observed in pleural exudates (a) collected from WT mice. 
The absence of TNF-α receptor 1 gene in mice (TNF-
αR1KO) as well as the treatment of WT mice with Etaner-
cept significantly reduced the pleural exudate production of 
TNF-α. Similarly, a significant increase of the TNF-α (b) was 
observed in the lung tissues from carrageenan-injected WT 
mice at 4 and 24 hours after carrageenan. In the lung tissues 
from carrageenan-injected TNF-αR1KO mice as well as of 
WT mice which have received with Etanercept the TNF-α 
levels were significantly reduced in comparison to those of 
WT animals measured in the same conditions. Data are 
means ± SEM of 10 mice for each group. *P < 0.01 vs. SHAM; 
°P < 0.01 vs. carrageenan- WT group.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of TNF-α in the lung Figure 2
Immunohistochemical localization of TNF-α in the lung. No positive staining for TNF-α was observed in the lung tissues col-
lected at 24 hours from sham WT mice (a) and from sham TNF-αR1KO mice (b). On the contrary, tissue sections obtained 
from WT animals at 4 h (c) and at 24 hours (d) after carrageenan injection demonstrate positive staining for TNF-α mainly 
localized in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall. In carrageenan-injected TNF-αR1KO 
mice, no positive staining for TNF-α were observed in the lung tissues collected at 4 h (e) and at 24 hours (f). Similarly, the 
treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the 
positive staining for TNF-α in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall in the lung tissues col-
lected at 4 h (g) and at 24 hours (h). Figure is representative of at least 3 experiments performed on different experimental 
days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Typical Densitometry evaluation Figure 3
Typical Densitometry evaluation. Densitometry analysis of immunocytochemistry photographs (n = 5 photos from each 
sample collected from all mice in each experimental group) for TNF-α, Bax, Bcl-2 Claudin-2, Claudin-4, Claudin-5, ZO-I and β-
catenin from lung tissues was assessed. The assay was carried out by using Imaging Densitometer (AxioVision, Zeiss, Milan, 
Italy) on a personal computer. Data are expressed as % of total tissue area. *P < 0.01 vs. SHAM; °P<0.01 vs. carrageenan- WT 
group ND: not detectable.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Effects of TNF-α gene deletion and Etanercept 
administration on apoptosis in acute lung inflammation
To test whether functional TNF-α gene plays a role on
apoptosis in acute lung inflammation, we measured
TUNEL-like staining in the lung tissues at 4 h and 24 h
after carrageenan administration. Almost no apoptotic
cells were detected in the lung from sham-treated (Fig.
4asee (TUNEL)-positive cells count Fig 4h). At 4 h (Fig.
4bb1see (TUNEL)-positive cells count Fig 4h) and 24 h
(Fig. 4cc1see (TUNEL)-positive cells count Fig 4h) after
the induction of lung inflammation by carrageenan
administration, lung tissues demonstrated a marked
appearance of dark brown apoptotic cells and intercellular
apoptotic fragments. The presence of apoptotic cells or
fragments were significantly reduced in the absence of a
functional TNF-α R1 gene in TNF-αR1KO mice at 4 h (Fig.
4dsee (TUNEL)-positive cells count Fig 4h) and at 24
hours (Fig. 4esee (TUNEL)-positive cells count Fig 4h)
after carrageenan. Similarly, the treatment of WT mice
with Etanercept (5 mg/kg administered sc 2 h prior carra-
geenan) visibly and significantly reduced the number of
apoptotic cells or fragments in the lung tissues collected at
4 h (Fig. 4fsee (TUNEL)-positive cells count Fig 4h) and
at 24 hours (Fig. 4gsee (TUNEL)-positive cells count Fig
4h).
Moreover, samples of lung tissue were taken at 4 and 24 h
after carrageenan administration in order to determine
the immunohistological staining for Bax and Bcl-2.
No positive staining for Bax was observed in the lung tis-
sues collected at 4 h (data not shown) and at 24 hours
from sham WT mice (Fig. 5asee densitometry analysis
Fig. 3a) and from sham TNF-αR1KO mice (Fig. 5bsee
densitometry analysis Fig. 3b). On the contrary, tissue
sections obtained from WT animals at 4 h (data not
shown see densitometry analysis Fig. 3a) and at 24 hours
(Fig. 5csee densitometry analysis Fig. 3b) after carra-
geenan injection demonstrate positive staining for Bax. In
carrageenan-injected TNF-αR1KO mice, no positive stain-
ing for Bax were observed in the lung tissues collected at 4
h (data not shown, see densitometry analysis Fig. 3a)
and at 24 hours (Fig. 5dsee densitometry analysis Fig.
3b). Similarly, the treatment of WT mice with Etanercept
(5 mg/kg administered sc 2 h prior carrageenan) reduced
the degree of positive staining for Bax in the lung tissues
at 4 h (data not shown, see densitometry analysis Fig.
3a) and at 24 hours (Fig. 5esee densitometry analysis Fig.
3b).
In addition, lung tissue sections from sham WT mice (Fig.
6asee densitometry analysis Fig. 3b) and from sham
TNF-αR1KO mice (Fig. 6bsee densitometry analysis Fig.
3b) demonstrated Bcl-2 positive staining while in the lung
from carrageenan-treated WT mice the staining signifi-
cantly reduced at 4 h (data not shown, see densitometry
analysis Fig. 3a) and at 24 hours (Fig. 6csee densitometry
analysis  Fig. 3a). In carrageenan-injected TNF-αR1KO
mice, a regular presence of Bcl-2 distribution was
observed in the lung tissues collected at 4 h (data not
shown, see densitometry analysis Fig. 3a) and at 24
hours (Fig. 6dsee densitometry analysis Fig. 3b). Simi-
larly, the treatment of WT mice with Etanercept (5 mg/kg
administered sc 2 h prior carrageenan) attenuated the loss
of positive staining for Bcl-2 in the lung tissues at 4 h
(data not shown, see densitometry analysis Fig. 3a) and
at 24 hours (Fig. 6e, see densitometry analysis Fig. 3a).
Lower levels of leukocyte extravasation and of tissue 
permeability correlate with a different modulation of TNF-
α gene deletion and Etanercept administration on 
epithelian/endothelial function during pleurisy
It is known that pro-inflammatory mediators modulate
epithelial and endothelial function, which, in turn, favors
the extravasation and recruitment of leukocytes further
amplifying the inflammatory response. Therefore, we
investigate the role of functional TNF-α gene on the poly-
morphonuclear cells (PMNs) in the pleural cavity. When
compared to the number of cells collected from the pleu-
ral space from sham WT mice and sham TNF-αR1KO
mice, injection of carrageenan induced a significant time
dependent increase in the number of PMNs (Fig. 7a). The
number of inflammatory cells (Fig. 7a) in the pleural cav-
ity at 4 and 24 hours after carrageenan administration was
significantly reduced in the absence of a functional TNF-
αR1 gene in TNF-αR1KO mice. Similarly, treatment of WT
mice with Etanercept (5 mg/kg administered s.c. 2 h prior
carrageenan) significantly reduced the inflammatory cell
infiltration in the pleaural cavity (Fig. 7a).
The important presence of inflammatory cells in the pleu-
ral cavity appeared to be correlated with the influx of leu-
kocytes into the lung tissue. Therefore, we investigate the
role of functional TNF-α gene on the neutrophils infiltra-
tion by measurement of the activity of myeloperoxidase.
Myeloperoxidase activity was significantly elevated (p <
0.001) at 4 h and 24 h after carrageenan injection in WT
mice (Fig. 7b). In lung from TNF-αR1KO mice myeloper-
oxidase activity was significantly reduced at 4 h and at 24
hours (p < 0.01) in comparison to those of WT animals
(Fig. 7b). Similarly, the treatment of WT mice with Etaner-
cept (5 mg/kg administered s.c. 2 h prior carrageenan) sig-
nificantly reduced the neutrophils infiltration in the lung
tissues at 4 h and at 24 hours after carrageenan-injection
(Fig. 7b).
During the inflammatory process, tissue permeability is
modified in part by changes in tight junctions [2,36].
Since ZO-1 is implicated in tight junction regulation and
was used as a marker of cellular barrier integrity [37], weRespiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Effects of TNF-α gene deletion and Etanercept administration on apoptosis Figure 4
Effects of TNF-α gene deletion and Etanercept administration on apoptosis. Almost no apoptotic cells were detected in the 
lung from sham-treated (a) tissues collected at 24 hours. At 4 h (bb1) and 24 h (cc1) after the induction of lung inflammation 
by carrageenan administration, lung tissues demonstrated a marked appearance of dark brown apoptotic cells and intercellular 
apoptotic fragments. The presence of apoptotic cells or fragments were significantly reduced in the absence of a functional 
TNF-α R1 gene in TNF-αR1KO mice at 4 h (d) and at 24 hours (e) after carrageenan. Similarly, the treatment of WT mice 
with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) visibly and significantly reduced the number of apoptotic cells 
or fragments in the lung tissues collected at 4 h (f) and at 24 hours (g). The graph (h) shows the mean ± SE of percentage 
TUNEL positive epithelial cells in biopsies from mice in all the experimental groups. *P < 0.01 vs. SHAM; °P < 0.01 vs. carra-
geenan- WT group ND: not detectable. Figure is representative of at least 3 experiments performed on different experimental 
days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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performed immunoistochemistry experiments to evaluate
ZO-1 distribution in lung sections. Results indicate that in
the lung tissues collected at 4 h (data not shown see den-
sitometry analysis Fig. 3a) and at 24 hours from sham WT
mice (Fig. 8asee densitometry analysis Fig. 3b) and from
sham TNF-αR1KO mice (Fig. 8bsee densitometry analy-
sis Fig. 3b), ZO-1 was uniformly and continuously dis-
tributed along the alveolar epithelium and the vascular
endothelium. In contrast, a significant disruption of
immuno-signal for ZO-1 was observed along the alveolar
Immunohistochemical localization of Bax in the lung Figure 5
Immunohistochemical localization of Bax in the lung. Lung biopsies were taken 24 h after injection of carrageenan. No positive 
staining for Bax was observed in the lung tissues collected at 24 hours from sham WT mice (a) and from sham TNF-αR1KO 
mice (b). On the contrary, tissue sections obtained from WT animals at 24 hours (c) after carrageenan injection demonstrate 
positive staining for TNF-α mainly localized in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall. In car-
rageenan-injected TNF-αR1KO mice, no positive staining for Bax were observed in the lung tissues collected at 24 hours (d). 
Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly 
reduced the positive staining for Bax in the infiltrated inflammatory cells, pneumocytes as well as in vascular wall in the lung tis-
sues collected at 24 hours (e). Figure is representative of at least 3 experiments performed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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epithelium and the vascular endothelium in the lung sec-
tions of carrageenan-treated WT mice at 4 h (Fig. 8csee
densitometry analysis Fig. 3a) and at 24 hours (Fig.
8dsee densitometry analysis Fig. 3b) after carrageenan.
In lungs of carrageenan-treated TNF-αR1KO mice, a more
regular distribution pattern of ZO-1 along the alveolar
epithelium and the vascular endothelium was found at 4
h (Fig. 8esee densitometry analysis Fig. 3a) and at 24
hours (Fig. 8fsee densitometry analysis Fig. 3b), thus
indicating that in carrageenan-treated TNF-αR1KO mice
Immunohistochemical localization of Bcl-2 in the lung Figure 6
Immunohistochemical localization of Bcl-2 in the lung. Lung biopsies were taken 24 h after injection of carrageenan. Lung tissue 
sections collected at 24 hours from sham WT mice (a) and from sham TNF-αR1KO mice (b) demonstrated Bcl-2 positive 
staining while in the lung from carrageenan-treated WT mice the staining significantly reduced and at 24 hours (c). In carra-
geenan-injected TNF-αR1KO mice, a regular presence of Bcl-2 distribution was observed in the lung tissues collected at 24 
hours (d). Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered sc 2 h prior carrageenan) attenuated the 
loss of positive staining for Bcl-2 in the lung tissues at 24 hours (e). Figure is representative of at least 3 experiments per-
formed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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carrageenan treatment provokes a lower degree of disor-
ganization of ZO-1. Similarly, the treatment of WT mice
with Etanercept (5 mg/kg administered s.c. 2 h prior car-
rageenan) visibly and significantly reduced the disorgani-
zation of ZO-1 in the lung tissues collected at 4 h (Fig.
8gsee densitometry analysis Fig. 3a) and at 24 hours (Fig.
8hsee densitometry analysis Fig. 3b).
In addition, results indicate that in the lung tissues col-
lected at 4 h (data not shown see densitometry analysis
Fig. 3a) and at 24 hours from sham WT mice and from
sham TNF-αR1KO mice, Claudin-2 (Fig. 9a,brespectively
see densitometry analysis Fig. 3b), Claudin-4 (Fig.
10a,brespectively see densitometry analysis Fig. 3b),
Claudin-5 (Fig. 11a,brespectively see densitometry anal-
ysis Fig. 3b) and β-catenin (Fig. 12a,brespectively, see
densitometry analysis Fig. 3b) were uniformly and con-
tinuously distributed along the alveolar epithelium and
the vascular endothelium. On the contrary, a significant
disruption of immunohistochemical localization signal
for Claudin-2 (Fig. 9cdrespectively), Claudin-4 (Fig.
10bcrespectively), Claudin-5 (Fig. 11cdrespectively) and
β-catenin (Fig. 12cdrespectively)  was observed in the
lung tissues sections of carrageenan-treated WT mice at 4
h (see densitometry analysis Fig. 3a) and 24 h (see den-
sitometry analysis Fig. 3b) after carrageenan. In lungs of
carrageenan-treated TNF-αR1KO mice was found less
irregular distribution pattern of Claudin-2 (Fig.
9efrespectively), Claudin-4 (Fig. 10derespectively), Clau-
din-5 (Fig. 11efrespectively)  and  β-catenin (Fig.
12efrespectively) at 4 h (see densitometry analysis Fig.
3a) and at 24 hours (see densitometry analysis Fig. 3a).
Similarly, the treatment of WT mice with Etanercept (5
mg/kg administered s.c. 2 h prior carrageenan) were able
to prevent carrageenan-induced distribution alteration of
Claudin-2 (Fig. 9ghrespectively), Claudin-4 (Fig.
10efrespectively), Claudin-5 (Fig. 11ghrespectively) and
β-catenin (Fig. 12ghrespectively) at 4 h (see densitome-
try analysis Fig. 3a) and at 24 hours (see densitometry
analysis Fig. 3a).
A massive increase in the lung permeability was observed
at 4 and 24 h after carrageenan administration, as evi-
denced by a marked increase in the pleural exudates for-
mation in WT mice (Fig. 12). Significant reduction of
pleural exudates formation was observed at 4 and 24 h
after carrageenan administration in carrageenan-treated
TNF-αR1KO mice as well as increase in the carrageenan-
treated WT mice which have received Etanercept (5 mg/kg
administered s.c. 2 h prior carrageenan) (Fig. 12).
Discussion
The gas exchanging air-blood barriers in the lung are com-
posed of the microvascular pulmonary endothelium and
the epithelial lining of the alveoli, which form three sepa-
rate compartments: blood, interstitium, and the alveolar
space. Acute lung injury and its most severe form, the
acute respiratory distress syndrome (ARDS), are condi-
tions characterized by a diffuse, intense inflammatory
process, by damage to both endothelial and epithelial cell
barriers, resulting in marked extravasation of vascular
Effects of TNF-α gene deletion and Etanercept administra- tion on carrageenan-induced accumulation of polymorphonu- clear cells in pleural cavity (a) and neutrophils infiltration in  the lung tissues (b) Figure 7
Effects of TNF-α gene deletion and Etanercept administra-
tion on carrageenan-induced accumulation of polymorphonu-
clear cells in pleural cavity (a) and neutrophils infiltration in 
the lung tissues (b). A significant polymorphonuclear cells 
infiltration (a) was observed in pleural cavity of WT mice at 4 
h and 24 h after carrageenan administration. The absence of 
TNF-α receptor 1 gene in mice (TNF-αR1KO) as well as the 
treatment of WT mice with Etanercept significantly reduced 
the number of inflammatory cells in the pleural cavity (a) at 4 
and 24 hours after carrageenan injection. In addition, at 4 and 
24 hrs, the neutrophils infiltration by measurement of the 
activity of myeloperoxidase. Myeloperoxidase activity was 
significantly elevated at 4 h and 24 h after carrageenan admin-
istration in WT mice. In TNF-αR1KO mice lung myeloper-
oxidase activity was significantly reduced at 4 h and at 24 
hours. Similarly, the treatment of WT mice with Etanercept 
(5 mg/kg administered s.c. 2 h prior carrageenan) significantly 
reduced the neutrophils infiltration in the lung tissues at 4 h 
and at 24 hours after carrageenan administration. Data are 
means ± SEM of 10 mice for each group. *P < 0.01 vs. SHAM; 
°P < 0.01 vs. carrageenan- WT group.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of ZO-1 in the lung Figure 8
Immunohistochemical localization of ZO-1 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) 
and from sham TNF-αR1KO mice (b), ZO-1 was uniformly and continuously distributed along the alveolar epithelium and the 
vascular endothelium. In contrast, a significant disruption of immuno-signal for ZO-1 was observed along the alveolar epithe-
lium and the vascular endothelium in the lung sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after car-
rageenan. In lungs of carrageenan-treated TNF-αR1KO mice, a more regular distribution pattern of ZO-1 along the alveolar 
epithelium and the vascular endothelium was found at 4 h (e) and at 24 hours (f), thus indicating that in carrageenan-treated 
TNF-αR1KO mice carrageenan treatment provokes a lower degree of disorganization of ZO-1. Similarly, the treatment of WT 
mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) visibly and significantly reduced the disorganization of 
ZO-1 in the lung tissues collected at 4 h (g) and at 24 hours (h). Figure is representative of at least 3 experiments performed 
on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of Claudin-2 in the lung Figure 9
Immunohistochemical localization of Claudin-2 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) 
and from sham TNF-αR1KO mice (b), Claudin-2 were uniformly and continuously distributed along the alveolar epithelium 
and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-
2 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. 
In lungs of carrageenan-treated TNF-αR1KO mice was found less irregular distribution pattern of Claudin-2 at 4 h (e) and at 
24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carra-
geenan) were able to prevent carrageenan-induced distribution alteration of Claudin-2 at 4 h (g) and at 24 hours (h) after car-
rageenan. Figure is representative of at least 3 experiments performed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of Claudin-4 in the lung Figure 10
Immunohistochemical localization of Claudin-4 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) 
and from sham TNF-αR1KO mice (b), Claudin-4 were uniformly and continuously distributed along the alveolar epithelium 
and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-
4 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. 
In lungs of carrageenan-treated TNF-αR1KO mice was found less irregular distribution pattern of Claudin-4 at 4 h (e) and at 
24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carra-
geenan) were able to prevent carrageenan-induced distribution alteration of Claudin-4 at 4 h (g) and at 24 hours (h) after car-
rageenan. Figure is representative of at least 3 experiments performed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of Claudin-5 in the lung Figure 11
Immunohistochemical localization of Claudin-5 in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) 
and from sham TNF-αR1KO mice (b), Claudin-5 were uniformly and continuously distributed along the alveolar epithelium 
and the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for Claudin-
5 was observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. 
In lungs of carrageenan-treated TNF-αR1KO mice was found less irregular distribution pattern of Claudin-5 at 4 h (e) and at 
24 hours (f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carra-
geenan) were able to prevent carrageenan-induced distribution alteration of Claudin-5 at 4 h (g) and at 24 hours (h) after car-
rageenan. Figure is representative of at least 3 experiments performed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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Immunohistochemical localization of β-catenin in the lung Figure 12
Immunohistochemical localization of β-catenin in the lung. In lung tissue sections collected at 24 hours from sham WT mice (a) 
and from sham TNF-αR1KO mice (b), β-catenin were uniformly and continuously distributed along the alveolar epithelium and 
the vascular endothelium. On the contrary, a significant disruption of immunohistochemical localization signal for β-catenin was 
observed in the lung tissues sections of carrageenan-treated WT mice at 4 h (c) and at 24 hours (d) after carrageenan. In lungs 
of carrageenan-treated TNF-αR1KO mice was found less irregular distribution pattern of β-catenin at 4 h (e) and at 24 hours 
(f) after carrageenan. Similarly, the treatment of WT mice with Etanercept (5 mg/kg administered s.c. 2 h prior carrageenan) 
were able to prevent carrageenan-induced distribution alteration of β-catenin at 4 h (g) and at 24 hours (h) after carrageenan. 
Figure is representative of at least 3 experiments performed on different experimental days.Respiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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fluid [38]. The filling of alveolar spaces by proteinaceous
edema fluid and inflammatory cells leads to severe hypox-
emia and respiratory failure [38]. The normal functioning
of the lung depends on the establishment and mainte-
nance of a milieu in the alveolar space that is distinct from
the composition of the subepithelial compartment. This
process depends on the formation and proper functioning
of specialized structures, called tight junctions (TJ),
between adjacent cells making up the epithelial sheet. The
TJ is a complex of several integral membrane proteins and
peripheral membrane proteins that interact strongly with
the cytoskeleton [39]. Integral membrane proteins
involved in TJ formation include occludin and members
of a large class of proteins called claudins [39]. These pro-
teins contain four transmembrane domains and are
thought to be the points of cell-to-cell contact within the
TJ [40]. Cosedimentation assays of TJ proteins suggest that
there is a strong interaction between occludin and another
protein associated with TJ formation, zonula occludens
(ZO)-1 [41,42]. ZO-1 has been shown to interact with the
cytoplasmic tails of occludin and the claudins. In addi-
tion, ZO-1 interacts with two additional members of the
membrane-associated guanylate kinase family of proteins,
ZO-2 and ZO-3 [43]. The TJ serves as a fence that differen-
tiates the plasma membrane into apical and basolateral
domains [44]. TJs also serve as a regulated semipermeable
barrier that limits the passive diffusion of solutes across
the paracellular pathway between adjacent cells [45].
These properties of TJs, in combination with transcellular
vectorial transport processes, generate distinct internal
environments in the opposing compartments.
Recently, we have demonstrated, using an experimental
model of colitis, that the structure and function of TJs in
the intestinal epithelial is dependent of the production of
proinflammatory cytokines (e.g. TNF-α) [34]. In particu-
lar in one study, we have showed that the structure and
function of TJs in the ileum were altered in mice at 4 days
after the induction of experimental colitis [34]. These
changes were ameliorated when mice were treated with
Thalidomide. In the study reported here, we obtained
similar results and showed that the structure and function
of TJs in the lung were altered in mice injected 4 and 24 h
earlier with carrageenan. Moreover, these changes were
ameliorated by treatment with Etanercept, a TNF-α solu-
ble receptor construct, as well as in mice with a targeted
deletion of the TNF-αR1 gene. As a result of these efforts,
we point out that acute lung inflammation induced alter-
ations in the function of lungs, is due, at least in part, to
massive changes in the expression and localization of key
TJ proteins. Furthermore, we propose that excessive TNF-
α production is an important component of this process.
What is then the mechanism by which inhibition of TNF-
α induced the structure and function of TJs alteration in
acute inflammation caused by carrageenan?
There is good evidence that TNF-α help to propagate the
extension of a local or systemic inflammatory process
[46,47]. We confirm here that carrageenan injection a sub-
stantial increase of TNF-α in the exudates and lung tissues
which likely contribute in different capacities to the evo-
lution of acute inflammation. As expected, the TNF-α lev-
els were abolished in TNF-αR1KO mice and significantly
reduced in the TNF-α R1WT mice treated with Etanercept.
Moreover various study have clearly point out that the
immune system plays an important role in modulating
epithelial permeability in different organs such us gut and
lung [48,49]. The regulation of epithelial barrier function
by cytokines has been studied most extensively in the gut
using different epithelial cell line. For examples some
studies have demonstrated that two cytokines, interferon-
γ (IFNγ) and tumor necrosis factor-α (TNFα), decreased
barrier function of cultured intestinal epithelial monolay-
ers [50,51]. Moreover, incubation of intestinal epithelial
cell monolayers with both IFNγ and TNFα leads to reor-
ganization of many tight junction proteins, including ZO-
1, junction adhesion molecule 1, occludin, claudin-1, and
claudin-4 [27]. The effects of pro-inflammatory cytokines
on lung epithelial barrier function were studied using
lung epithelial cells. In a recent study Ahdieh and col-
leagues have clearly demonstrated Th1 and Th2 cytokines
have distinct activities in lung epithelial cells that are con-
sistent with the role of these cytokines in lung inflamma-
tion (e.g. asthma) In particular, IL-4 and IL-13 disrupt
epithelial barrier function and wound healing, both of
which would be expected to exacerbate inflammation. In
contrast, IFN-γ enhances epithelial barrier function and
wound healing, which would contribute to a reduction in
inflammation [49].
In the present study, we also demonstrate that carra-
geenan administration to mice induced an alteration of
immunohistochemical localization signal for ZO-1, Clau-
din-2, Claudin-4, Claudin-5 and β-catenin at 4 h and 24 h
after carrageenan. The genetic or pharmacological inhibi-
tion of TNF-α abolished the alteration of tight junction
permeability. Thus, a key step in the pathogenesis of acute
lung injury may be myosin light chain kinase activation
by TNFα, leading to epithelial barrier dysfunction. There
is extensive literature examining the consequences of spe-
cific proinflammatory cytokines, particularly tumor
necrosis factor (TNF)-α, on the induction of apoptosis. An
important biologic effect of TNF-α is the induction of
apoptosis through its interaction with its receptor, TNFR.
However, the same TNF-TNFR ligand-receptor interaction
can also activate NF-κB [52]. Activation of the Fas ligandRespiratory Research 2007, 8:75 http://respiratory-research.com/content/8/1/75
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is another major signaling pathway that leads to apopto-
sis. In bronchial epithelial cells, ligation of Fas stimulates
both apoptosis and expression of IL-8 [53]. Thus, the acti-
vation of proinflammatory signaling pathways can elicit
apoptotic responses as well as the expression of cytokines.
The response of the normal airway epithelial cell to
inflammatory stimuli may consist of activation of both
apoptotic and proinflammatory cascades [52]. However,
in diseases such as acute lung injury, in which there
appears to be an excessive inflammatory response, the
balance between the activation and suppression of these
potentially opposing pathways may be abnormal. In the
present study, using the tunnel coloration we have clearly
confirmed that TNF-α plays an important role in the
induction of apoptosis during acute lung injury and that
the treatment with etanercept and genetic inhibition of
TNF-αR1 attenuates the degree of apoptosis. Moreover, it
is well known that Bax, a pro-apoptotic gene, plays an
important role in developmental cell death (34). Simi-
larly, it has been shown that the overexpression of Bcl-2,
a known antiapoptotic factor, significantly reduced the
bronchial as well as intestinal epithelial apoptosis
[54,55]. Base on these evidences, we have identified proa-
poptotic transcriptional changes, including upregulation
of proapoptotic Bax and down regulation of antiapoptotic
Bcl-2 by immunohystochemical staining. We report in the
present study for the first time that the treatment with
etanercept and genetic inhibition of TNF-α R1prevents the
lost of the antiapoptotic way and reduced the proapop-
totic pathway activation with a mechanism still to dis-
cover.
Further studies are needed to address this point. Thus, we
propose the following cycle: Inflammation -> TNF-α->
endothelial/epithelial TJ alteration -> PMN infiltration ->
more pro-inflammatory mediator release -> organ dam-
age. The confirmation of this proposed feedback cycle,
however, requires further investigation. In conclusion, we
have demonstrated in vivo that the pharmacological inhi-
bition of TNF-α by Etanercept attenuates the development
of TJ alteration in acute inflammation in mice.
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